Skip to content

Clinical trials

Phase 2 Parkinson Disease trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 2 Country / region: Netherlands Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20151
20161
20171
20201
20223
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
UCB Biopharma SRL2
University Medical Center Groningen2
Bial R&D Investments, S.A.1
Biogen1
Boehringer Ingelheim1
GEN İlaç ve Sağlık Ürünleri A.Ş.1
Integrative Research Laboratories AB1
University Hospital, Lille1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease12
Basal Ganglia Diseases1
Central Nervous System Diseases1
Hallucinations1
Movement Disorders1
Neurodegenerative Diseases1
Parkinsonian Disorders1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.